Call for Abstract

International Conference On Oncology Nursing, will be organized around the theme “Caring is the Essence of Cancer Nursing”

Euro Oncology Nursing 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Oncology Nursing 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Oncology nurses practice in a variety of settings including acute care hospitals, ambulatory care clinics, private oncologists' offices, radiation therapy facilities, home healthcare agencies, and community agencies. The roles of the oncology nurses vary from the intensive care focus of bone marrow transplantation to the community focus of cancer screening, detection, and prevention. Health includes motivating people to embrace behaviors that both improve their emotional and physical quality of life and reduce their risk for premature morbidity and mortality. Although the majority of adults treated for cancer in the United States live free of disease for many years, many survivors experience lasting side effects and complications of treatment. Others encounter recurrences or new cancers that require additional treatment. Late effects vary from one cancer survivor to the next. They can range from very mild to serious. Medical experts can’t always predict if or when they will occur. Some effects might improve or go away with time such as anemia. Patients with advanced cancer are willing to pay more for all aspects of a good end-of-life experience compared with healthy older adults. Both groups are willing to pay more to be pain free and to die at home. This Session Includes Track Cancer Genetics: Genetic Counseling, Ethical Issues, and the Nurse’s Role, Health Promotion, Late Effects of Cancer Treatment and Long-Term Survivorship Issues, End-of-Life Issues, Psychological and Family Issues, Nursing-Sensitive Patient Outcomes, Translation Science, Cancer Epidemiology, Palliative Care.

  • Track 1-1Health Promotion
  • Track 1-2Late Effects of Cancer Treatment and Long-Term Survivorship Issues
  • Track 1-3End-Of-Life Issues
  • Track 1-4Psychological and Family Issues
  • Track 1-5Nursing-Sensitive Patient Outcomes
  • Track 1-6Translation Science
  • Track 1-7Cancer Epidemiology
  • Track 1-8Cancer Epidemiology

Organ/Tumor specific cancers are cancers named basing on the location of cancer in the body organ. Cancer can affect just about every organ in the human body. Each type of cancer is unique with its own causes, symptoms, and methods of treatment. Lung cancer was the most common cancer worldwide in men contributing nearly 17% of the total number of new cases diagnosed in 2012 and became an important topic for World Cancer Conferences. The top three, lung, prostate and colorectal cancers, contributed nearly 42% of all cancers (excluding non-melanoma skin cancer).There are more than 200 different types of cancer, but Breast cancer, Head & Neck cancer, Blood, lung and leukemia cancer cancers that are diagnosed with the greatest frequency. Lung cancer, also known as carcinoma of the lung or pulmonary carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Cancer genetics is now one of the fastest expanding medical specialties. However, some people inherit mutation in the germ line. The mutations occur in two classes of cellular genes: oncogenes and tumor suppressor genes. This Session Includes Head and neck cancers, Gastrointestinal cancers, Lung Cancer, colorectal cancer, Melanoma, Hematologic cancers, Robotics in oncological Surgery, Translational approach in cancer treatment.

  • Track 2-1Head and Neck Cancers
  • Track 2-2Gastrointestinal Cancers
  • Track 2-3Translational Approach in Cancer Treatment
  • Track 2-4Lung Cancer
  • Track 2-5Melanoma
  • Track 2-6Hematologic Oncology
  • Track 2-7Colo-rectal Cancer

The majority of people with cancer will experience pain at some time or another. The pain can result from the cancer itself, or from the cancer's treatment. In addition, some people who have been cured of their cancer can continue to suffer from pain. Cancer pain, or the discomfort that stems from cancer and its treatment, can be controlled most of the time, in which a nurse plays a important role. There are many different medicines and methods available to control cancer pain. People who have cancer and are feeling pain need to inform their doctor immediately. The earlier pain treatment is started, the more effective it may be. Comprehensive pain assessment is one of the most important initial steps for successful pain. This Session includes Treating Cancer Pain, Non-Drug Pain Treatment, Chemotherapy in Cancer Pain and Pain-relieving therapies.

  • Track 3-1Treating Cancer Pain
  • Track 3-2Non-Drug Pain Treatment
  • Track 3-3Pain Relieving Therapies
  • Track 3-4Chemotherapy in Cancer Pain

The scope of this study entails the current immunologic therapeutics markets for several of the most common cancers. The sectors covered are colony stimulating factors (CSFs), interferon Alfa and gamma products, interleukin products and therapeutic monoclonal antibodies, including antibody conjugates, cancer vaccines and other cancer treatment immunology products. Vaccines against HPV and hepatitis B are included; while such vaccines act only indirectly against cancer, they do serve to protect against the disease. Also covered is oncolytic virology, so new that its market tables have been presented separately from the immunotherapy tables. The report also includes discussion of the regulatory environment, current and developing technologies, cancer incidence, market projections and market share, along with latest trends and clinical trials. Stem cell transplant (also called peripheral blood stem cell transplant) is a treatment to try to cure some types of cancer, such as leukemia, lymphoma and myeloma. You have very high doses of chemotherapy, sometimes with whole body radiotherapy. This Session Includes Stem cell mediated immuno gene therapy for tumors, Challenges and new opportunities with antibody drugs, Tumor-host interactions, nuclear responses and tumorigenesis, Cancer Biomarkers, Diagnostic and Prognostic Cancer Biomarkers, Cancer-induced immunosuppressive cells, Immune system stimulation, acquired assistance.

  • Track 4-1Stem cell mediated immuno gene therapy for tumors
  • Track 4-2Challenges and new opportunities with antibody drugs
  • Track 4-3Tumour-host interactions, nuclear responses and tumorigenesis
  • Track 4-4Cancer biomarkers, Diagnostic and Prognostic Cancer Biomarkers
  • Track 4-5Cancer-induced immuno suppressive cells.

It is the term for medical products and practices that are not part of standard medical care.

Some CAM therapies have undergone careful evaluation and have found to be safe and effective. However there are others that have been found to be ineffective or possibly harmful. Less is known about many CAM therapies, and research has been slower for a number of reasons:

Time and funding issues, Problems finding institutions and cancer researchers to work with on the studies and Regulatory issues

CAM therapies need to be evaluated with the same long and careful research process used to evaluate standard treatments. Standard cancer treatments have generally been studied for safety and effectiveness through an intense scientific process that includes clinical trials with large numbers of patients. This Session Includes Alternative Medical Systems, Mind-Body Methods, Nutritional Methods, Pharmacologic and Biologic Treatments.


  • Track 5-1Alternative Medical Systems
  • Track 5-2Mind-Body Methods
  • Track 5-3Nutritional Methods
  • Track 5-4Pharmacologic and Biologic Treatments

A cancer diagnosis and its treatment can be overwhelming. Usually patients and family members have many questions and concerns about the disease and the treatment. The supportive care program helps patients and family members deal with the physical and emotional distress caused by the cancer diagnosis and treatment. The less distress patients have, the more energy they can direct toward recovery.

Comprehensive supportive care services require the expertise of an interdisciplinary team in order to adequately assess and treat the complex needs of cancer patients and their families. This Session Includes Art therapy, Child psychiatry, Music Therapy, Nutrition & Supplements, Physical, occupational, & speech therapies, Parent link program, Social work, Cancer Rehabilitation & Rehabilitation, Diet and exercise and Spiritual Counseling.


  • Track 6-1Art therapy
  • Track 6-2Child psychiatry
  • Track 6-3Nutrition & Supplements
  • Track 6-4Physical, occupational, & speech therapies
  • Track 6-5Parent link program
  • Track 6-6Social work

The landscape of Cancer treatment has dramatically changed over the last four decades. The age when surgery and radiotherapy were the only effective way to fight tumor growth has ended. A complex scenario where the molecular features of tumors seem to be the cornerstone of any therapy is now emerging. Here we provide an overview on the different approaches to cancer treatment. This will help the reader to acknowledge the pivotal role of some classic cancer therapies, including surgery, radiation, chemotherapy and endocrine therapy, now better understood in the mechanisms underpinning their efficacy. Following, we focus on the understanding of the value of systemic treatment and on an up-date on the novel, up-coming therapies of the current targeted therapy age, including new antibodies, small molecules, antiangiogenics and viral therapy. We briefly elaborate, finally, on new biomarkers development and how it should rule and determine the future of therapeutic research in cancer. This Session Includes Radiotherapy and chemotherapy, Molecular-targeted therapies, Cancer: Gene expression and protein profiling; Surgery and laparoscopy, Hormone replacement therapy, Cancer Metabolism, Latest drug developments in Neuro oncology, Innovational combinational therapies.

  • Track 7-1Molecular-targeted therapies
  • Track 7-2Cancer: Gene expression and protein profiling; Surgery and laparoscopy
  • Track 7-3Hormone replacement therapy
  • Track 7-4Cancer Metabolism
  • Track 7-5Latest drug developments in Neuro oncology
  • Track 7-6Innovational combinational therapies

Anti-Cancer monoclonal antibodies can be targeted against malignant cells by several mechanisms. Tissue-specific gene delivery using immune liposomes has also been achieved in brain, and breast cancer tissue. Antibody-directed enzyme pro drug therapy involves the application of cancer associated monoclonal antibodies which are linked to a drug-activating enzyme. Subsequent systemic administration of a non-toxic agent results in its conversion to a toxic drug, and resulting in a cytotoxic effect which can be targeted at malignant cells. A cancer vaccine is a vaccine that either treats existing cancer or prevents development of a cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines. There are currently no vaccines able to prevent all cancers. However vaccines against some oncoviruses have proven extremely effective. Treatment often fails when cancer becomes resistant to anti-cancer drugs. Knowledge of all the human genes and their functions may allow effective preventive measures, and change drug research strategy and drug discovery development processes. This Session Includes Functional genomics in drug discovery and development, Therapeutic antibodies and cancer vaccines, Novel drug delivery system and cancer drug designing, Anticancer drugs in global market: economy and their cost effectiveness, Nanotechnology in cancer drugs, Cancer clinical trials, Regulatory issues in cancer research, Drug compounds targeting Tumor metabolism, CAR T-Cell Therapy, Oncolytic viral therapies , Gene therapy, Adoptive T-Cell transfer.

  • Track 8-1Functional genomics in drug discovery and development
  • Track 8-2Gene-therapy
  • Track 8-3Oncolytic viral therapies
  • Track 8-4CAR T-Cell Therapy
  • Track 8-5Drug compounds targeting Tumor metabolism

North America has the major market share of 43.97% followed by Europe, which accounted for about 38% of the overall CD market in 2013. North America and Europe together accounted for over 82% in the global CD market in 2013 and they would continue to be the major markets through 2020. This is mainly due to the increasing incidence of cancer and other diseases and higher health care awareness in these regions. Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. The key driver for this market is an increase in research and development of targeted drugs, which require a corresponding companion diagnostic. This Session Includes Cancer screening and early detection & prevention, Molecular diagnostics, Digital cancer pathology and imaging, Personalized genomics and clinical biomarkers, Diffuse optical imaging, Magnetic resonance imaging, Positron emission tomography, Computed tomography, Structural and functional imaging, Radioactive compounds in Neuroimaging, Biomarker Discovery.

  • Track 9-1Cancer screening and early detection & prevention
  • Track 9-2Radioactive compounds in NeuroImaging
  • Track 9-3Structural and functional imaging
  • Track 9-4Computed tomography
  • Track 9-5Positron emission tomography

Breast Cancer is the most common cause of death in women. We first need to understand how cancer develops in the body for reducing breast cancer risk.  Current understanding of the biology of breast cancer is very important and its relevance to treating and preventing the disease. Breast cancer is not a one disease. For example, understanding that breast tissue of girls and young women is especially sensitive to cancer causing agents can help direct risk reduction efforts to these groups. Making sense of cancer denotes taking a step toward more apprised decisions about our bodies, ourselves and our environment. This Session Includes Biology of Breast Cancer, Role of Nurse in Breast Cancer Care, Breast Cancer Treatment Side Effects, Innovative Therapeutic Approaches, and Optimal Breast Cancer Pathology Organization.

  • Track 10-1Biology of Breast Cancer
  • Track 10-2Role of Nurse In Breast Cancer Care
  • Track 10-3Breast Cancer Treatment Side Effects
  • Track 10-4Innovative Therapeutic Approaches
  • Track 10-5Optimal Breast Cancer Pathology – Organisation

Surgical Oncology nursing provides you with a detailed examination of surgical patients with cancer from diagnosis to survivorship. Caring for surgical patients with cancer involves a diverse healthcare team with many hands touching patients at different stages. In today's changing climate, oncology nurses work much more closely with a diverse team of healthcare professionals and having an intimate knowledge of surgical patients with cancer and the treatment process has become even more important. This Session Includes Preoperative Care of Patient with Cancer, Surgical Care of Breast Cancer, Surgical Care of Brain Tumors, Robotics in Oncological Surgery, Reconstructive Surgery, and Survivorship Issues in Surgical Oncology Nursing.

  • Track 11-1Preoperative Care of Patient with Cancer
  • Track 11-2Surgical Care of Breast Cancer
  • Track 11-3Surgical Care of Brain Tumors
  • Track 11-4Robotics in Oncological Surgery
  • Track 11-5Survivorship Issues in Surgical Oncology Nursing
  • Track 11-6Reconstructive Surgery

Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies because of the high unmet need for improved treatments for multiple types of cancer. For an oncologist or an oncology nurse, finding the appropriate words to comfort a family who is facing the loss of a loved one can be difficult. This section addresses how different groups—oncologists, patients, and Nurses—think about end-of-life care issues. This section discusses an oncologist's responsibility and perspective when it comes to difficult subjects such as advanced cancer, hospice, do not resuscitate orders, cytotoxic therapy, supportive care, maintaining a patient's dignity, and imminent death. Articles in this series also discuss the role of spirituality and religion at the time of death, and the importance of good communication between the oncologist and family members throughout the dying process.

  • Track 12-1 Clinical implications and Oncology Nursing Practice
  • Track 12-2Primary Care and Oncology Nursing
  • Track 12-3Oncology Nursing and Cancer care
  • Track 12-4Psychological and psychosocial aspects and Cancer care
  • Track 12-5Effects of Cancer in chemotherapy and Oncology Nursing
  • Track 12-6Oncology Nursing in USA
  • Track 12-7Management of side effects from surgery, chemotherapy, and radiation